CN116926054B - Armoured probiotics with catalytic function and preparation method thereof - Google Patents
Armoured probiotics with catalytic function and preparation method thereof Download PDFInfo
- Publication number
- CN116926054B CN116926054B CN202310668278.5A CN202310668278A CN116926054B CN 116926054 B CN116926054 B CN 116926054B CN 202310668278 A CN202310668278 A CN 202310668278A CN 116926054 B CN116926054 B CN 116926054B
- Authority
- CN
- China
- Prior art keywords
- solution
- armoured
- probiotics
- probiotic
- bacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 106
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 106
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 230000003197 catalytic effect Effects 0.000 title claims abstract description 11
- 239000000243 solution Substances 0.000 claims abstract description 92
- 230000001580 bacterial effect Effects 0.000 claims abstract description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 44
- 230000000529 probiotic effect Effects 0.000 claims abstract description 28
- 239000006228 supernatant Substances 0.000 claims abstract description 19
- 102000019197 Superoxide Dismutase Human genes 0.000 claims abstract description 16
- 108010012715 Superoxide dismutase Proteins 0.000 claims abstract description 16
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims abstract description 14
- 102000016938 Catalase Human genes 0.000 claims abstract description 14
- 108010053835 Catalase Proteins 0.000 claims abstract description 14
- 239000001263 FEMA 3042 Substances 0.000 claims abstract description 14
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims abstract description 14
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims abstract description 14
- 229940033123 tannic acid Drugs 0.000 claims abstract description 14
- 235000015523 tannic acid Nutrition 0.000 claims abstract description 14
- 229920002258 tannic acid Polymers 0.000 claims abstract description 14
- 239000007993 MOPS buffer Substances 0.000 claims abstract description 12
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 11
- 239000007864 aqueous solution Substances 0.000 claims abstract description 11
- 239000001110 calcium chloride Substances 0.000 claims abstract description 11
- 229910001628 calcium chloride Inorganic materials 0.000 claims abstract description 11
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 9
- 229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 9
- 235000011010 calcium phosphates Nutrition 0.000 claims abstract description 9
- 238000005119 centrifugation Methods 0.000 claims abstract description 9
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 9
- 239000011259 mixed solution Substances 0.000 claims abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 38
- 241000894006 Bacteria Species 0.000 claims description 28
- 238000005406 washing Methods 0.000 claims description 11
- 239000002244 precipitate Substances 0.000 claims description 7
- 230000009514 concussion Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 6
- 241001052560 Thallis Species 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 38
- 239000012530 fluid Substances 0.000 description 34
- 239000007788 liquid Substances 0.000 description 30
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 27
- 239000006059 cover glass Substances 0.000 description 24
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 20
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 20
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 235000010323 ascorbic acid Nutrition 0.000 description 19
- 229960005070 ascorbic acid Drugs 0.000 description 19
- 239000011668 ascorbic acid Substances 0.000 description 19
- 230000000968 intestinal effect Effects 0.000 description 19
- 230000029087 digestion Effects 0.000 description 17
- 230000002496 gastric effect Effects 0.000 description 17
- 239000008188 pellet Substances 0.000 description 12
- 230000006378 damage Effects 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 11
- 239000008223 sterile water Substances 0.000 description 11
- 239000007990 PIPES buffer Substances 0.000 description 10
- 239000008367 deionised water Substances 0.000 description 10
- 229910021641 deionized water Inorganic materials 0.000 description 10
- 229910001629 magnesium chloride Inorganic materials 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 10
- 235000019796 monopotassium phosphate Nutrition 0.000 description 10
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 10
- 239000001103 potassium chloride Substances 0.000 description 10
- 235000011164 potassium chloride Nutrition 0.000 description 10
- 235000017557 sodium bicarbonate Nutrition 0.000 description 10
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- 238000005538 encapsulation Methods 0.000 description 9
- 210000001035 gastrointestinal tract Anatomy 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 230000004083 survival effect Effects 0.000 description 8
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 5
- 108010019160 Pancreatin Proteins 0.000 description 5
- 102000057297 Pepsin A Human genes 0.000 description 5
- 108090000284 Pepsin A Proteins 0.000 description 5
- 239000001099 ammonium carbonate Substances 0.000 description 5
- 235000012501 ammonium carbonate Nutrition 0.000 description 5
- 239000003833 bile salt Substances 0.000 description 5
- 229940093761 bile salts Drugs 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 238000004132 cross linking Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000000834 fixative Substances 0.000 description 5
- 238000011010 flushing procedure Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 230000036542 oxidative stress Effects 0.000 description 5
- 229940055695 pancreatin Drugs 0.000 description 5
- 229940111202 pepsin Drugs 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000002791 soaking Methods 0.000 description 5
- 238000009210 therapy by ultrasound Methods 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000008827 biological function Effects 0.000 description 4
- 238000007747 plating Methods 0.000 description 4
- 238000010668 complexation reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 238000012876 topography Methods 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000001546 nitrifying effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012536 packaging technology Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
- C12Y111/01—Peroxidases (1.11.1)
- C12Y111/01006—Catalase (1.11.1.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
- C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
- C12Y115/01001—Superoxide dismutase (1.15.1.1)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to the technical field of probiotics, and discloses a armoured probiotic with a catalytic function and a preparation method thereof, wherein catalase and superoxide dismutase solution are added into tannic acid aqueous solution, and then the mixed solution and Fe are added 3+ Aqueous solution addition of aqueous bacterial solution (OD 600 In the process of the preparation method, =1), MOPS buffer is added into the oscillated solution, supernatant is removed by centrifugation, the solution is washed three times by sterilized water, centrifugation is carried out, thalli are collected, the thalli are resuspended in ice bath calcium phosphate solution containing calcium chloride, L100-55 solution is added, pH is adjusted to be below 4-5, and the armoured probiotics are obtained by centrifugation and collection.
Description
Technical Field
The invention relates to the technical field of probiotics, in particular to a armoured probiotic with a catalytic function and a preparation method thereof.
Background
At present, most of the commonly used probiotics embedding and delivering technologies are large-volume encapsulation or multicellular encapsulation, namely, a large amount or a plurality of probiotics are encapsulated in hydrogel or a polymer film, and the volume after encapsulation is often more than tens of microliters. The encapsulation with excessive volume is unfavorable for the transmission of substances, and is easy to cause the problems of metabolite accumulation, insufficient nutrient supply and the like, thereby influencing the normal growth and functions of the encapsulated cells. Meanwhile, an excessively thick encapsulation layer is not beneficial for the encapsulated probiotics to respond quickly to external or host environmental changes. In addition, the number of probiotics packaged by the multicellular packaging technology is randomly distributed and is nonuniform in size, the nonuniform size and the number of probiotics are difficult to accurately control the number of transplanted probiotics in clinical application, and the stability is low. As reported in the paper 'study of nitrifying bacteria embedding immobilization conditions', polyethylene glycol and sodium alginate are adopted to embed and immobilize bacteria to form 2-3mm pellets, and each embedding condition has a certain influence on degradation of immobilized pellets. In order to solve the defects and shortcomings in the technology, the invention provides a preparation method of a plant polyphenol armor shell for encapsulating probiotics by single cells, the technology can realize independent encapsulation of single cells, and the encapsulated armor shell can protect the probiotics from oxidative stress damage and resist gastrointestinal tract digestive environment. In addition, the armor shell can be shelled by mild biomolecules, and the probiotics after shelled can immediately recover growth and maintain the original biological functions of the probiotics.
Disclosure of Invention
(one) solving the technical problems
Aiming at the defects of the prior art, the invention provides the armoured probiotics with the catalytic function and the preparation method thereof, which realize the independent encapsulation of single cells, protect the probiotics from oxidative stress damage, resist gastrointestinal tract digestion environment, and keep the original biological functions of the probiotics after the shell is opened.
(II) technical scheme
1. The preparation method of the armoured probiotics with the catalytic function comprises the following steps:
adding catalase and superoxide dismutase solution into tannic acid water solution, manually shaking for 10-30s, and mixing the above solution and Fe 3+ The aqueous solution was added sequentially with an aqueous bacterial solution (OD 600 In=1), the manual shake is repeated for 10-30s. Adding MOPS buffer into the oscillated solution, oscillating for 10-30s manually, centrifuging, removing supernatant, washing precipitate with sterilized water for 3 times, and centrifuging. Resuspension it in ice bath calcium phosphate solution containing calcium chloride, adding L100-55 solution to adjust pH of the solution to 4-5, centrifuging and collecting to obtain the armoured probiotics.
Preferably, the concentration of the catalase, superoxide dismutase and tannic acid solution is 300-400U/ml, 1800-2500U/ml and 5-20mM.
Preferably, the Fe 3+ The concentration of the aqueous solution is 5-20mM.
Preferably, the MOPS buffer is at a concentration of 10-20mM and is adjusted to 7-8 using a pH meter.
Preferably, the two centrifugation parameters are 10000-12000rpm, 10-30min.
Preferably, the concentration of the calcium chloride is 8-15M.
Preferably, the concentration of the L100-55 solution is 1-5mg/mL.
Preferably, the concentration of the hydrochloric acid solution is 0.1-0.5M.
(III) beneficial technical effects
Adding catalase and superoxide dismutase solution into tannic acid water solution, and mixing the above solution and Fe 3+ The aqueous solution was added sequentially with an aqueous bacterial solution (OD 600 In=1), MOPS buffer was added to the shaken solution, the supernatant was removed by centrifugation, and the solution was centrifuged with sterile water. Re-suspending in ice bath calcium phosphate solution containing calcium chloride, adding L100-55 solution and hydrochloric acid solution,regulating pH to 4-5, swirling, centrifuging and collecting to obtain the armoured probiotics.
The single-cell encapsulation of the probiotics can be realized quickly, and the encapsulation armor shell can protect the probiotics from oxidative stress damage and resist gastrointestinal tract digestion environment. In addition, the armor shell can be shelled by mild biomolecules, and the probiotics after shelled can immediately recover growth and maintain the original biological functions of the probiotics.
Drawings
FIG. 1 is Fe 3+ Cross-linking complexation and de-cross-linking patterns of tannic acid.
FIG. 2 is Fe 3+ -cross-linking complexation of tannic acid and de-cross-linking uv spectra. TA: tannic acid; AA: ascorbic acid
FIG. 3 is a scanning electron microscope topography. EcN: coli Nissle 1917 probiotic; coated EcN: armoured probiotics
Fig. 4 is a scanning electron microscope topography. EcN: coli Nissle 1917 probiotic; coated EcN: armoured probiotics
Figure 5 is a probiotic growth curve. EcN: coli Nissle 1917 probiotic; coated EcN: armoured probiotics
Figure 6 is a graph of probiotic bacteria against oxidative stress damage by hydrogen peroxide. EcN: coli Nissle 1917 probiotic; coated EcN: armoured probiotics
Figure 7 is the survival rate of probiotics following simulated gastric fluid digestion. EcN: coli Nissle 1917 probiotic; coated EcN: armoured probiotics
Figure 8 is the survival rate of probiotics following simulated intestinal fluid digestion. EcN: unpackaged probiotics; coated EcN: encapsulated probiotics
Detailed Description
Example 1
1 preparation of armoured probiotics
Preparing 350U/ml catalase and 2000U/ml superoxide dismutase solution, adding 6 μl catalase and 30 μl superoxide dismutase into 125 μl10 mM tannic acid water solution, manually shaking for 20s, and mixing the above solution and 125 μl10 mM Fe 3+ The aqueous solution was added sequentially with 250. Mu.L of an aqueous bacterial solution (OD 600 In=1), the manual concussion is repeated for 20s. 10mM MOPS buffer was prepared and adjusted to 7.2 with a pH meter. Adding 0.5 mM OPS buffer solution into the above oscillated bacterial solution, manually oscillating for 20s, centrifuging at 12000rpm for 10min, removing supernatant, washing precipitate with sterilized water for 3 times, and centrifuging at 12000rpm for 10min.
Resuspension it in ice bath calcium phosphate solution containing 0.9mL of 8M calcium chloride, shake for 5min manually, add 1mL of 1mg/mL L100-55 solution, continue to add 80 μl of 0.1M hydrochloric acid solution, adjust pH of the solution to 4-5 using pH meter, and collect by centrifugation to obtain the armoured probiotics.
2 removing probiotics armor
The packed bacterial pellet was resuspended in 500. Mu.L of phosphate buffer, shaken well, centrifuged to remove the supernatant, the bacterial pellet was resuspended in 1mL of ascorbic acid, and allowed to stand for 10min to remove the bacterial armor shell.
3 determination of growth curve
1mL OD 600 Bacterial liquids=1, divided into three groups: the unembossed group, the embedded group and the unshelling group were removed after 4 hours of embedding, the OD value of the bacterial liquid was measured with an ultraviolet spectrophotometer every 1 hour, and the data were recorded.
4 scanning electron microscope for observing the shape of the bacteria
Taking a cover glass, soaking the cover glass in 1M hydrochloric acid overnight, then flushing the cover glass with absolute ethyl alcohol for three times, carrying out ultrasonic treatment, and drying the cover glass for later use. The samples were fixed in 5mM PIPES buffer (fixative) pH 6.5 containing 2% glutaraldehyde and allowed to stand overnight. The next day was washed 4 times with 5mM PIPES buffer pH 6.5, centrifuged to remove the supernatant, and lyophilized to obtain a powder, which was placed on a cover glass and observed by a scanning electron microscope.
5 in vitro gastrointestinal tract simulated digestion experiment
All digestion processes were carried out at 37℃and the digests were prepared as follows:
simulated gastric fluid (simulated gastric fluid, SGF) sodium bicarbonate (2.1 g), sodium chloride (2.758 g), magnesium chloride (0.1 mM), potassium chloride (0.515 g), potassium dihydrogen phosphate (0.122 g) and ammonium carbonate (0.048 g) were dissolved in 1000ml deionized water and the pH was adjusted to 2.5 with hydrochloric acid. Pepsin (final 2000U/ml) was added to the solution before use. Samples from bacterial fluids were mixed with simulated gastric fluid at a volume ratio of 1:1 and the pH was adjusted to 2.0. The mixture was stirred continuously at 100rpm for 2h at 37 ℃. The liquid was then diluted to plate and counted.
Simulated intestinal fluid (simulated intestinal fluid, SIF) sodium bicarbonate (7.138 g), sodium chloride (2.244 g), magnesium chloride (0.35 mM), potassium chloride (0.511 g) and potassium dihydrogen phosphate (0.112 g) were dissolved in 1000mL deionized water, and the pH was adjusted to 7.0. Prior to use, bile salts (10 mM) and pancreatin (1:3000) were added to the solution. The bacterial liquid sample and the simulated intestinal liquid were mixed in a volume ratio of 1:1, and the pH was adjusted to 7.0. The mixture was stirred continuously at 100rpm for 2h at 37 ℃. The liquid was then diluted to plate and counted.
6 experiment against Hydrogen peroxide damage
Dispersing thallus in 250 μl of 0.1%, 0.2%, 0.5%, and 1% hydrogen peroxide solution, centrifuging for 30min and 1 hr, cleaning with sterile water for 3 times, and adding ascorbic acid to remove tannic acid-Fe 3+ Washing the shell with sterile water for 3 times, dispersing into 250 μl of culture medium, plating, and counting bacteria.
Example 2
1 preparation of armoured probiotics
Preparing 400U/ml catalase and 2500U/ml superoxide dismutase solution, adding 10 μl catalase and 50 μl superoxide dismutase into 150 μl 20mM tannic acid water solution, manually shaking for 30s, and mixing the above solution and 130 μl 20mM Fe 3+ The aqueous solution was added sequentially with 300. Mu.L of an aqueous bacterial solution (OD 600 In=1), the manual shake is repeated for 30s. Preparing 20mM MOPS buffer, adjusting to 7.2 with pH meter, adding 0.5 mM OPS buffer to the well-shocked thallus solution, manually shocking for 30s, centrifuging at 12000rpm for 30min, removing supernatant, washing precipitate with sterilized water for 3 times, centrifuging at 12000rpm for 10min, and collecting thallus.
The strain is resuspended in ice-bath calcium phosphate solution containing 1mL of 12M calcium chloride, 1mL of 3mg/mL L100-55 solution is added, 60 mu L of 0.3M hydrochloric acid solution is continuously added, the pH value of the solution is adjusted to 4.8 by using a pH meter, and the armoured probiotics are obtained by centrifugal collection.
2 removing probiotics armor
The packed bacterial pellet was resuspended in 1000. Mu.L of phosphate buffer, shaken well, centrifuged to remove the supernatant, the bacterial pellet was resuspended in 4mL of ascorbic acid and allowed to stand for 10min to remove the bacterial armor shell.
3 determination of growth curve
Take 3mL OD 600 Bacterial liquids=1, divided into three groups: the unembossed group, the embedded group and the unshelling group were removed 8h after embedding, the OD value of the bacterial liquid was measured with an ultraviolet spectrophotometer every 2h, and the data were recorded.
4 scanning electron microscope for observing the shape of the bacteria
Taking a cover glass, soaking the cover glass in 1.5M hydrochloric acid overnight, then flushing the cover glass with absolute ethyl alcohol for three times, carrying out ultrasonic treatment, and drying the cover glass for later use. The samples were fixed in 5mM PIPES buffer (fixative) pH 6.5 containing 4% glutaraldehyde and allowed to stand overnight. The next day was washed 8 times with 5mM PIPES buffer pH 6.5, centrifuged to remove the supernatant, and lyophilized to obtain a powder, which was placed on a cover glass and observed by a scanning electron microscope.
5 in vitro gastrointestinal tract simulated digestion experiment
All digestion processes were carried out at 37℃and the digests were prepared as follows:
simulated gastric fluid (simulated gastric fluid, SGF) sodium bicarbonate (2.3 g), sodium chloride (2.655 g), magnesium chloride (0.1 mM), potassium chloride (0.520 g), potassium dihydrogen phosphate (0.122 g) and ammonium carbonate (0.048 g) were dissolved in 1000ml deionized water and the pH was adjusted to 2.3 with hydrochloric acid. Pepsin (final 2000U/ml) was added to the solution before use. Samples from bacterial fluids were mixed with simulated gastric fluid at a volume ratio of 1:1 and the pH was adjusted to 2.0. The mixture was stirred continuously at 150rpm for 2h at 37 ℃. The liquid was then diluted to plate and counted.
Simulated intestinal fluid (simulated intestinal fluid, SIF) sodium bicarbonate (7.247 g), sodium chloride (2.186 g), magnesium chloride (0.32 mM), potassium chloride (0.532 g) and potassium dihydrogen phosphate (0.119 g) were dissolved in 1000mL deionized water and the pH was adjusted to 7.0. Prior to use, bile salts (10 mM) and pancreatin (1:3000) were added to the solution. The bacterial liquid sample and the simulated intestinal liquid were mixed in a volume ratio of 1:1, and the pH was adjusted to 7.0. The mixture was stirred continuously at 120rpm for 4h at 37 ℃. The liquid was then diluted to plate and counted.
6 experiment against Hydrogen peroxide damage
Dispersing thallus in 300 μl of 0.1%, 0.2%, 0.5%, and 1% hydrogen peroxide solution, centrifuging for 30min and 1 hr respectively, cleaning with sterile water for 3 times, and adding ascorbic acid to remove tannic acid-Fe 3+ The shell is washed by sterile water for 6 times, finally dispersed into 300 mu L of culture medium, plated and counted.
Example 3
1 preparation of armoured probiotics
Preparing 300U/ml catalase and 1800U/ml superoxide dismutase solution, adding 6 μl catalase and 30 μl superoxide dismutase into 125 μl 5mM tannic acid water solution, manually shaking for 10s, and mixing the above solution and 125 μl 5mM Fe 3+ The aqueous solution was added sequentially with 250. Mu.L of an aqueous bacterial solution (OD 600 In=1), the manual shake is repeated for 10s. Preparing 10mM MOPS buffer, adjusting pH to 7 with pH meter, adding into 0.5mL of the shake solution, manually shaking for 10s, centrifuging at 10000rpm for 10min, removing supernatant, washing precipitate with sterilized water for 2 times, centrifuging at 10000rpm for 10min, and repeating the above steps.
Resuspension it in ice bath calcium phosphate solution containing 0.9mL of 12.5M calcium chloride, shake for 10min manually, then add 1mL of 1mg/mL L100-55 solution, continue to add 80 μl of 0.1M hydrochloric acid solution, adjust the pH of the solution to 4.4 using a pH meter, and collect the armoured probiotics by centrifugation.
2 removing probiotics armor
The packed bacterial pellet was resuspended in 800. Mu.L of phosphate buffer, shaken well, centrifuged to remove the supernatant, the bacterial pellet was resuspended in 1mL of ascorbic acid and allowed to stand for 20min to remove the bacterial armor shell.
3 determination of growth curve
2mL of bacterial liquid with OD=1 is taken and divided into three groups: the unembossed group, the embedded group and the unshelling group were removed after 4 hours of embedding, the OD value of the bacterial liquid was measured with an ultraviolet spectrophotometer every 2 hours, and the data were recorded.
4 scanning electron microscope for observing the shape of the bacteria
Taking a cover glass, soaking the cover glass in 1M hydrochloric acid overnight, then flushing the cover glass with absolute ethyl alcohol for three times, carrying out ultrasonic treatment, and drying the cover glass for later use. The samples were fixed in 5mM PIPES buffer (fixative) pH 6.5 containing 2% glutaraldehyde and allowed to stand overnight. The next day was washed 6 times with 5mM PIPES buffer pH 6.5, centrifuged to remove the supernatant, and lyophilized to obtain a powder, which was placed on a cover glass and observed by a scanning electron microscope.
5 in vitro gastrointestinal tract simulated digestion experiment
All digestion processes were carried out at 37℃and the digests were prepared as follows:
simulated gastric fluid (simulated gastric fluid, SGF) sodium bicarbonate (2.056 g), sodium chloride (2.745 g), magnesium chloride (0.1 mM), potassium chloride (0.508 g), potassium dihydrogen phosphate (0.122 g) and ammonium carbonate (0.048 g) were dissolved in 1000ml deionized water and the pH was adjusted to 2.5 with hydrochloric acid. Pepsin (final 2000U/ml) was added to the solution before use. Samples from bacterial fluids were mixed with simulated gastric fluid at a volume ratio of 1:1 and the pH was adjusted to 2.0. The mixture was stirred continuously at 100rpm for 2h at 37 ℃. The liquid was then diluted to plate and counted.
Simulated intestinal fluid (simulated intestinal fluid, SIF) sodium bicarbonate (7.138 g), sodium chloride (2.244 g), magnesium chloride (0.33 mM), potassium chloride (0.507 g) and potassium dihydrogen phosphate (0.109 g) were dissolved in 1000mL deionized water, and the pH was adjusted to 7.0. Prior to use, bile salts (10 mM) and pancreatin (1:3000) were added to the solution. The bacterial liquid sample and the simulated intestinal liquid were mixed in a volume ratio of 1:1, and the pH was adjusted to 7.0. The mixture was stirred continuously at 100rpm for 2h at 37 ℃. The liquid was then diluted to plate and counted.
6 experiment against Hydrogen peroxide damage
Dispersing thallus in 250 μl of 0.1%, 0.2%, 0.5%, and 1% hydrogen peroxide solution, centrifuging for 1 hr and 2 hr respectively, cleaning with sterile water for 3 times, adding ascorbic acid to remove tannic acid-Fe 3+ Washing the shell with sterile water for 3 times, dispersing into 250 μl of culture medium, plating, and counting bacteria.
Example 4
1 preparation of armoured probiotics
Preparing 380U/ml catalase and 2200U/ml superoxide dismutase solution, adding 8 μl catalase and 25 μl superoxide dismutase into 150 μl 15mM tannic acid water solution, manually shaking for 15s, mixing the above solution and 130 μl 18mM Fe 3+ The aqueous solution was added sequentially with 250. Mu.L of an aqueous bacterial solution (OD 600 In=1), the manual concussion is repeated for 20s. Preparing 15mM MOPS buffer, adjusting to 7.5 with pH meter, adding 1.5mL of the shaking solution, manually shaking for 10s, centrifuging at 12000rpm for 15min, removing supernatant, washing the precipitate with sterilized water for 4 times, centrifuging at 12000rpm for 15min, and repeating the above steps.
Resuspension it in ice bath calcium phosphate solution containing 1mL 15M calcium chloride, shake for 20min manually, add 3mL 5mg/mL L100-55 solution, continue to add 80 μL 0.5M hydrochloric acid solution, adjust pH of the solution to 4.2 with pH meter, centrifugate and collect to obtain the armoured probiotic.
2 removing probiotics armor
The packed bacterial pellet was resuspended in 500. Mu.L of phosphate buffer, shaken well, centrifuged to remove the supernatant, the bacterial pellet was resuspended in 1mL of ascorbic acid, and allowed to stand for 10min to remove the bacterial armor shell.
3 determination of growth curve
1mL of bacterial liquid with OD=1 is taken and divided into three groups: the unembossed group, the embedded group and the unshelling group were removed 4 hours after embedding, the OD value of the bacterial liquid was measured once every other hour by using an ultraviolet spectrophotometer, and the data were recorded.
4 scanning electron microscope for observing the shape of the bacteria
Taking a cover glass, soaking the cover glass in 1M hydrochloric acid overnight, then flushing the cover glass with absolute ethyl alcohol for three times, carrying out ultrasonic treatment, and drying the cover glass for later use. The samples were fixed in 5mM PIPES buffer (fixative) pH 6.5 containing 2% glutaraldehyde and allowed to stand overnight. The next day was washed 4 times with 5mM PIPES buffer pH 6.5, centrifuged to remove the supernatant, and lyophilized to obtain a powder, which was placed on a cover glass and observed by a scanning electron microscope.
5 in vitro gastrointestinal tract simulated digestion experiment
All digestion processes were carried out at 37℃and the digests were prepared as follows:
simulated gastric fluid (simulated gastric fluid, SGF) sodium bicarbonate (2.1 g), sodium chloride (2.758 g), magnesium chloride (0.1 mM), potassium chloride (0.515 g), potassium dihydrogen phosphate (0.122 g) and ammonium carbonate (0.048 g) were dissolved in 1000ml deionized water and the pH was adjusted to 2.5 with hydrochloric acid. Pepsin (final 2000U/ml) was added to the solution before use. Samples from bacterial fluids were mixed with simulated gastric fluid at a volume ratio of 1:1 and the pH was adjusted to 2.0. The mixture was stirred continuously at 100rpm for 2h at 37 ℃. The liquid was then diluted to plate and counted.
Simulated intestinal fluid (simulated intestinal fluid, SIF) sodium bicarbonate (7.138 g), sodium chloride (2.244 g), magnesium chloride (0.33 mM), potassium chloride (0.507 g) and potassium dihydrogen phosphate (0.109 g) were dissolved in 1000mL deionized water, and the pH was adjusted to 7.0. Prior to use, bile salts (10 mM) and pancreatin (1:3000) were added to the solution. The bacterial liquid sample and the simulated intestinal liquid were mixed in a volume ratio of 1:1, and the pH was adjusted to 7.0. The mixture was stirred continuously at 100rpm for 2h at 37 ℃. The liquid was then diluted to plate and counted.
6 experiment against Hydrogen peroxide damage
Dispersing thallus in 250 μl of 0.1%, 0.2%, 0.5%, and 1% hydrogen peroxide solution, centrifuging for 30min and 1 hr, cleaning with sterile water for 3 times, and adding ascorbic acid to remove tannic acid-Fe 3+ Washing the shell with sterile water for 3 times, dispersing into 300 μl of culture medium, plating, and counting bacteria.
Example 5
1 preparation of armoured probiotics
Preparing 380U/ml hydrogen peroxidase and 2000U/ml superoxide dismutase solution, adding 6 μl hydrogen peroxidase and 30 μl superoxide dismutase into 125 μl 15mM tannic acid water solution, manually shaking for 15s, mixing the above solution and 125 μl10 mM Fe 3+ The aqueous solution was added sequentially to 300 μl of aqueous bacterial solution (od600=1) and the shaking was repeated manually for 30s. Preparing 15mM MOPS buffer, adjusting to 7.2 with pH meter, adding into 0.5mL of the shake solution, manually shaking for 30s, centrifuging at 10000rpm for 10min, removing supernatant, washing the precipitate with sterilized water for 4 times, centrifuging at 10000rpm for 10min, and repeating the above steps.
Resuspension it in ice bath calcium phosphate solution containing 0.9mL of 10M calcium chloride, shake for 10min manually, add 1mL of 2mg/mL L100-55 solution, continue to add 70 μl of 0.1M hydrochloric acid solution, adjust pH of the solution to 4.0 with pH meter, and collect by centrifugation to obtain the armoured probiotics.
2 removing probiotics armor
The packed bacterial pellet was resuspended in 300. Mu.L of phosphate buffer, shaken well, centrifuged to remove the supernatant, the bacterial pellet was resuspended in 2mL of ascorbic acid, and allowed to stand for 30min to remove the bacterial armor shell.
3 determination of growth curve
2mL of bacterial liquid with OD=1 is taken and divided into three groups: the unembossed group, the embedded group and the unshelling group were removed 4 hours after embedding, the OD value of the bacterial liquid was measured once every other hour by using an ultraviolet spectrophotometer, and the data were recorded.
4 scanning electron microscope for observing the shape of the bacteria
Taking a cover glass, soaking the cover glass in 1M hydrochloric acid overnight, then flushing the cover glass with absolute ethyl alcohol for three times, carrying out ultrasonic treatment,
and (5) drying for later use. The samples were fixed in 5mM PIPES buffer (fixative) pH 6.5 containing 2% glutaraldehyde and allowed to stand overnight. The next day was washed 4 times with 5mM PIPES buffer pH 6.5, centrifuged to remove the supernatant, and lyophilized to obtain a powder, which was placed on a cover glass and observed by a scanning electron microscope.
5 in vitro gastrointestinal tract simulated digestion experiment
All digestion processes were carried out at 37℃and the digests were prepared as follows:
simulated gastric fluid (simulated gastric fluid, SGF) sodium bicarbonate (2.022 g), sodium chloride (2.813 g), magnesium chloride (0.12 mM), potassium chloride (0.535 g), potassium dihydrogen phosphate (0.125 g) and ammonium carbonate (0.052 g) were dissolved in 1000ml deionized water and the pH was adjusted to 2.5 with hydrochloric acid. Pepsin (final 2000U/ml) was added to the solution before use. Samples from bacterial fluids were mixed with simulated gastric fluid at a volume ratio of 1:1 and the pH was adjusted to 2.0. The mixture was stirred continuously at 100rpm for 4h at 37 ℃. The liquid was then diluted to plate and counted.
Simulated intestinal fluid (simulated intestinal fluid, SIF) sodium bicarbonate (7.146 g), sodium chloride (2.238 g), magnesium chloride (0.38 mM), potassium chloride (0.521 g) and potassium dihydrogen phosphate (0.115 g) were dissolved in 1000mL deionized water and the pH was adjusted to 7.0. Prior to use, bile salts (10 mM) and pancreatin (1:3000) were added to the solution. The bacterial liquid sample and the simulated intestinal liquid were mixed in a volume ratio of 1:1, and the pH was adjusted to 7.0. The mixture was stirred continuously at 120rpm for 2h at 37 ℃. The liquid was then diluted to plate and counted.
6 experiment against Hydrogen peroxide damage
Dispersing thallus in 280 μl of 0.1%, 0.2%, 0.5%, and 1% hydrogen peroxide solution, centrifuging for 30min and 1 hr, cleaning with sterile water for 5 times, and adding ascorbic acid to remove tannic acid-Fe 3+ Washing the shell with sterile water for 5 times, dispersing into 280 mu L of culture medium, plating, and counting bacteria.
Detection result
As shown in fig. 1, fe3+ and tannic acid are both pale yellow, and when both 1:1 are mixed to give a greenish black color, indicating that the complexing reaction takes place immediately after mixing. Upon addition of ascorbic acid, the greenish black in the solution turned pale yellow, indicating that the complex had been destroyed. The concentration of ascorbic acid used in the experiment is usually 5-10mM, preferably 5mM, to ensure that the probiotic is not killed by ascorbic acid, and not more than 20mM.
FIG. 2 is a graph showing the ultraviolet spectrum of the crosslinking complexation and decrosslinking of Fe3+ -tannin. In the ultraviolet spectrum shown in FIG. 2, fe3+ has no ultraviolet absorption, and tannic acid-Fe3+ have similar ultraviolet absorption, and bacteria have absorption peaks at 250nm and 280 nm. After addition of ascorbic acid, the UV absorption was reduced to be close to that of Fe3+, indicating that the complex had been destroyed. The ascorbic acid treatment time is usually 10-15min, and in order to ensure that the complex has been destroyed, it is preferably shaken during the ascorbic acid treatment.
Fig. 3 is a scanning electron microscope morphology of the probiotic bacteria and the armoured probiotic bacteria of the present invention. The surface of the probiotics is wrinkled, the edge is sharp, and the surface of the probiotics subjected to the armor treatment is provided with a snowflake-shaped coating, and the outer side of the coating is loose. Normally the armoured probiotic is slightly larger than the unarmed probiotic to the naked eye under an electron microscope.
Fig. 4 is a scanning electron microscope morphology of the probiotics and the armoured probiotics of the invention. The probiotics are elliptical, the surface is flat, the edge is sharp, the surface of the probiotics subjected to the armor treatment is provided with a shell with lighter color, and the thickness of the shell is about 10-20nm; the cells were completely embedded. Typically the edge of the armoured probiotic is smoother than the edge of the probiotic.
Figure 5 is a graph of the growth of probiotics, armoium probiotics of the present invention. The probiotics enter logarithmic phase growth after 1h, but the armoured probiotics do not grow within 0-8h, and resume growth after 8h, which indicates that the armoured shell is automatically released at this time, and the armoured shell makes the bacteria in dormant state in 8h before, and does not kill the probiotics; the addition of ascorbic acid at 4 hours removed the armoured shell and the immediate recovery of the growth of the probiotic was found, further proving that the armour only put the bacteria in a dormant state and did not have an effect on the growth of the probiotic. The concentration of ascorbic acid used should be slightly lower, so that the embedding is released without inhibiting the growth of the cells.
Figure 6 is a graph of the resistance of probiotics of the present invention to oxidative stress damage by hydrogen peroxide. The probiotics and the armoured probiotics are respectively treated in hydrogen peroxide solutions with different concentrations for 30min and 1h,0.1% of hydrogen peroxide does not cause bacterial death, 0.5% of hydrogen peroxide has serious killing effect on the probiotics without the armoured probiotics, the killing effect is gradually enhanced along with the extension of the treatment time, almost all the probiotics are killed, but the armoured probiotics can resist the damage of high-concentration hydrogen peroxide, the viable count is still up to 106CFU/ml after the treatment for 1h, and the effective concentration of the probiotics is 106CFU/ml under the normal condition.
Figure 7 shows the survival rate of probiotics of the present invention after digestion with simulated gastric fluid. After the non-armoured probiotics are digested by artificial simulated gastric juice, the survival rate is obviously reduced, and the viable count is less than 104CFU/ml; the survival rate of the probiotics subjected to the armour is reduced, but the survival rate is obviously improved compared with that of probiotics not subjected to the armour, and the viable count is still up to 108CFU/ml after 2 hours of digestion. Proved that the armoured probiotics have stronger capability of resisting gastric acid degradation, and can be maintained for 2 hours without reduction.
Figure 8 shows the survival rate of probiotics of the present invention after simulated intestinal fluid digestion. The survival rate of the probiotics which are not subjected to the armour is not affected after the probiotics are digested by artificial simulation intestinal juice; the probiotic bacteria subjected to the armor are digested and initially packaged by the shell, so that the bacteria are in a dormant state, the number of viable bacteria is less than that of the probiotic bacteria not subjected to the armor, the armor is gradually released along with the time extension, the number of viable bacteria is gradually increased, and the number of the viable bacteria is more than that of the probiotic bacteria not subjected to the armor until 4 hours. Proved that the armoured probiotics can recover the activity of the non-armoured probiotics in the intestinal environment, immediately recover the growth and maintain the original biological functions of the probiotics.
Claims (5)
1. A armoured probiotic with catalytic function, characterized in that: the preparation method comprises the following steps:
adding catalase and superoxide dismutase solution into tannic acid water solution with concentration of 5-20mM, manually oscillating 10-30s, sequentially adding above mixed solution and 5-20mM Fe3+ water solution into OD 600 In bacterial aqueous solution=1, repeated manual concussion is 10-30 s; adding MOPS buffer with pH of 7-8 into the oscillated solution, oscillating manually for 10-30s, centrifuging, removing supernatant, washing precipitate with sterilized water for 2-6 times, and centrifuging; resuspension it in ice bath calcium phosphate solution containing calcium chloride, wherein the concentration of calcium chloride is 8-15M, adding 1-5mg/mL L100-55 solution and hydrochloric acid solution, adjusting pH of the solution to 4-5, centrifuging and collecting to obtain the armoured probiotic.
2. A catalytic armoured probiotic bacterium according to claim 1, characterized in that: the concentration of the catalase and superoxide dismutase is 300-400U/ml and 1800-2500U/ml respectively.
3. A catalytic armoured probiotic bacterium according to claim 1, characterized in that: the concentration of the MOPS buffer is 10-20mM, and the MOPS buffer is adjusted to 7-8 by a pH meter.
4. A catalytic armoured probiotic bacterium according to claim 1, characterized in that: the two times of centrifugation parameters are 10000-12000rpm and 10-30min.
5. A catalytic armoured probiotic bacterium according to claim 1, characterized in that: the concentration of the hydrochloric acid solution is 0.1-0.5M.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310668278.5A CN116926054B (en) | 2023-06-06 | 2023-06-06 | Armoured probiotics with catalytic function and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310668278.5A CN116926054B (en) | 2023-06-06 | 2023-06-06 | Armoured probiotics with catalytic function and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116926054A CN116926054A (en) | 2023-10-24 |
CN116926054B true CN116926054B (en) | 2024-01-23 |
Family
ID=88379567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310668278.5A Active CN116926054B (en) | 2023-06-06 | 2023-06-06 | Armoured probiotics with catalytic function and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116926054B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117297099A (en) * | 2023-11-07 | 2023-12-29 | 浙江大学 | Preparation method of probiotic coating based on sodium alginate and metal polyphenol network |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110711182A (en) * | 2019-10-29 | 2020-01-21 | 上海交通大学医学院附属仁济医院 | Surface-modified microorganism, and preparation method and application thereof |
CN111996148A (en) * | 2020-06-30 | 2020-11-27 | 上海交通大学医学院附属仁济医院 | Surface-modified microorganism, and preparation method and application thereof |
CN113499325A (en) * | 2021-07-08 | 2021-10-15 | 成都邦家乐君生物科技有限公司 | Biomass-based encapsulating material for probiotic activity protection and encapsulating method |
-
2023
- 2023-06-06 CN CN202310668278.5A patent/CN116926054B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110711182A (en) * | 2019-10-29 | 2020-01-21 | 上海交通大学医学院附属仁济医院 | Surface-modified microorganism, and preparation method and application thereof |
CN111996148A (en) * | 2020-06-30 | 2020-11-27 | 上海交通大学医学院附属仁济医院 | Surface-modified microorganism, and preparation method and application thereof |
CN113499325A (en) * | 2021-07-08 | 2021-10-15 | 成都邦家乐君生物科技有限公司 | Biomass-based encapsulating material for probiotic activity protection and encapsulating method |
Non-Patent Citations (3)
Title |
---|
Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies;Haojie Chen 等;Materials Today Bio.;第18卷;文章号:100543 * |
Ascorbic acid-mediated reductive disassembly of Fe3+-tannic acid shells in degradable single-cell nanoencapsulation;Hojae Lee 等;Chem. Commun.;第56卷(第89期);第13748-13751页 * |
Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy;Zhaoting Li 等;Adv. Mater.;第33卷;文章号:2102580 * |
Also Published As
Publication number | Publication date |
---|---|
CN116926054A (en) | 2023-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN116926054B (en) | Armoured probiotics with catalytic function and preparation method thereof | |
CN109554316B (en) | Bioremediation reagent for promoting plant growth and development and strengthening accumulation of heavy metals in polluted soil and remediation method | |
CN107446911B (en) | Microorganism embedding immobilized pellet and method thereof, special device and application | |
CN107902736B (en) | Preparation method of composite flocculation algistat and composite flocculation algistat | |
NO300252B1 (en) | Process for the preparation of a microgranular preparation | |
CN114886010B (en) | Preparation method of microecological preparation for pigs | |
CN106011040B (en) | One plant degradation Ofloxacin anthropi and its application | |
CN106177924A (en) | The preparation method of nanoscale lactoferrin chitosan particle | |
CN108004182A (en) | One plant of lactobacillus paracasei and its application in aquaculture | |
CN111996148A (en) | Surface-modified microorganism, and preparation method and application thereof | |
CN116144529A (en) | Rice saxophone OOR3-1 strain and application thereof | |
Mao et al. | Self-floating capsule of algicidal bacteria Bacillus sp. HL and its performance in the dissolution of Microcystis aeruginosa | |
Vijayalakshmi et al. | Industrial applications of alginate | |
CN114410617B (en) | Immobilization method for improving biological hydrogen synthesis of hydrogen-producing bacteria and application | |
CN111838677A (en) | Culturable enteric bacteria microcapsule and preparation method thereof | |
KR100484480B1 (en) | Encapsulation of Lactobacillus fermentum YL-3 | |
CN114223795A (en) | Preparation method of probiotic feed for piglets | |
CN105037596B (en) | The preparation method of the superparamagnetic carrier of crosslinked fixed fat enzyme | |
CN109964765B (en) | Weissella-based rice cadmium content reduction method | |
CN107162147B (en) | Preparation method and application of modified cucurbita pepo flocculant | |
CN109369864B (en) | Preparation method of block copolymer with photoresponse, reduction response and pH response | |
CN114317514B (en) | Immobilized microorganism pellet and preparation method and application thereof | |
CN115363216B (en) | Method for preparing probiotics microcapsule by fermentation tank airlift method | |
CN104162170B (en) | It is a kind of with the target gene nanoparticle of anti-endometriosis and preparation | |
CN114958649B (en) | Pediococcus acidilactici and application thereof in degradation of ochratoxin A |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |